These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8370164)

  • 1. Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants.
    Perraut R; Lussow AR; Gavoille S; Garraud O; Matile H; Tougne C; van Embden J; van der Zee R; Lambert PH; Gysin J
    Clin Exp Immunol; 1993 Sep; 93(3):382-6. PubMed ID: 8370164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.
    Barrios C; Lussow AR; Van Embden J; Van der Zee R; Rappuoli R; Costantino P; Louis JA; Lambert PH; Del Giudice G
    Eur J Immunol; 1992 Jun; 22(6):1365-72. PubMed ID: 1601031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.
    Lussow AR; Del Giudice G; Rénia L; Mazier D; Verhave JP; Verdini AS; Pessi A; Louis JA; Lambert PH
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2960-4. PubMed ID: 2183219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterial heat-shock proteins as carrier molecules.
    Lussow AR; Barrios C; van Embden J; Van der Zee R; Verdini AS; Pessi A; Louis JA; Lambert PH; Del Giudice G
    Eur J Immunol; 1991 Oct; 21(10):2297-302. PubMed ID: 1680693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen.
    Barrios C; Georgopoulos C; Lambert PH; Del Giudice G
    Clin Exp Immunol; 1994 Nov; 98(2):229-33. PubMed ID: 7955527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assays for adjuvanticity of new formulations and of carrier proteins for inducing antibody responses to selected immunogens in the squirrel monkey Saimiri sciureus.
    Perraut R; Chouteau P; Bourreau E; Bonnemains B; Garraud O
    Immunol Cell Biol; 1994 Apr; 72(2):169-75. PubMed ID: 8200692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.
    Zlotta AR; Drowart A; Huygen K; De Bruyn J; Shekarsarai H; Decock M; Pirson M; Jurion F; Palfliet K; Denis O; Mascart F; Simon J; Schulman CC; Van Vooren JP
    Clin Exp Immunol; 1997 Jul; 109(1):157-65. PubMed ID: 9218839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of antibodies induced after immunization of mice with the mycobacterial heat shock protein of 65 kD.
    Barrios C; Tougne C; Polla BS; Lambert PH; Del Giudice G
    Clin Exp Immunol; 1994 Nov; 98(2):224-8. PubMed ID: 7955526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.
    Arama C; Waseem S; Fernández C; Assefaw-Redda Y; You L; Rodriguez A; Radošević K; Goudsmit J; Kaufmann SH; Reece ST; Troye-Blomberg M
    Vaccine; 2012 Aug; 30(37):5578-84. PubMed ID: 21983157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp70: a carrier molecule with built-in adjuvanticity.
    Del Giudice G
    Experientia; 1994 Nov; 50(11-12):1061-6. PubMed ID: 7527346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
    Matsumoto S; Yukitake H; Kanbara H; Yamada T
    J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential use of heat-shock proteins to vaccinate against mycobacterial infections.
    Silva CL
    Microbes Infect; 1999 May; 1(6):429-35. PubMed ID: 10602675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl peptide adjuvants for Plasmodium falciparum and Plasmodium vivax circumsporozoite vaccines in rodent model systems.
    Bathurst IC; Gibson HL; Kansopon J; Hahm BK; Hollingdale MR; Barr PJ
    Biotechnol Ther; 1992; 3(1-2):15-34. PubMed ID: 1305890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
    Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
    Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.
    Behr C; Sarthou JL; Rogier C; Trape JF; Dat MH; Michel JC; Aribot G; Dieye A; Claverie JM; Druihle P
    J Immunol; 1992 Nov; 149(10):3321-30. PubMed ID: 1431109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.